1. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
2. Marcevich SYu, Tolpygina SN, Lukina YuV, Voronina VP, Kiseleva NV, Bojchenko ES, Dubinskaya RE, Hoseva EN. Comparative evaluation of the antiplatelet efficacy of the original and reproduced preparations of the intestinal-soluble form of acetylsalicylic acid (results of the ICAR clinical trial). Kardiologiya. 2012;52(1):74-82. (In Russ.)
3. 4 “P” MEDICINE AS A BASIS OF NEW SYSTEM OF PUBLIC HEALTH
4. Shlyahto EV, Konradi AO. Value — based medicine is a new paradigm in healthcare. Remedium Privolzh’e. 2018;163(3):4-8. (In Russ.)
5. Prikaz Minzdrava Rossii ot 13.02.13 №66 «Ob utverzhdenii strategii lekarstvennogo obespecheniya naseleniya Rossijskoj Federacii na period do 2025 goda i plana ee realizacii». Accessed July 07, 2022. (In Russ.). https://www.garant.ru/products/ipo/prime/doc/71280004/?ysclid=l7fwpip4vd919462266